» Articles » PMID: 17524580

Immunomodulation of RAW264.7 Macrophages by GLIS, a Proteopolysaccharide from Ganoderma Lucidum

Overview
Date 2007 May 26
PMID 17524580
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The immunomodulatory effect of Ganoderma lucidum immunomodulating substance (GLIS) on macrophages has been investigated as part of on-going research into the anti-cancer properties of Ganoderma lucidum. Proliferation of bone marrow macrophages (BMMs) was enhanced by GLIS in a dose-dependent manner. Microscopic examination revealed that numerous GLIS-treated RAW264.7 macrophages were enlarged and formed pseudopodia. Exposure of RAW264.7 macrophages to GLIS resulted in significant increases in NO production, induction of cellular respiratory burst activity, and increased levels of IL-1beta, IL-12p35 and IL-12p40 gene expression. Our data indicate that GLIS activates the immune system by modulating cytokine production.

Citing Articles

The Changes of Microbial Diversity and Isolation of Microorganism in Soil for Alleviating the Production Decreasing After Continuous Cultivation of Ganoderma lucidum.

Zaheer A, Tang C, Yang Y, Zhang J, Zhou S Curr Microbiol. 2024; 81(10):321.

PMID: 39177881 DOI: 10.1007/s00284-024-03852-0.


Liquid-Phase Adsorption Behavior of β-D-Glucooligosaccharides When Using Activated Carbon for Separation, and the Antioxidant Stress Activity of Purified Fractions.

Ma G, Jiang S, Liu L, Feng J, Zhang J, Li E Foods. 2024; 13(11).

PMID: 38890863 PMC: 11172381. DOI: 10.3390/foods13111634.


Pathophysiology and management of testicular ischemia/reperfusion injury: Lessons from animal models.

Akhigbe R, Odetayo A, Akhigbe T, Hamed M, Ashonibare P Heliyon. 2024; 10(9):e27760.

PMID: 38694115 PMC: 11058307. DOI: 10.1016/j.heliyon.2024.e27760.


Exploring the Therapeutic Potential of in Cancer.

Cancemi G, Caserta S, Gangemi S, Pioggia G, Allegra A J Clin Med. 2024; 13(4).

PMID: 38398467 PMC: 10889924. DOI: 10.3390/jcm13041153.


Natural Bio-Compounds from and Their Beneficial Biological Actions for Anticancer Application: A Review.

Cadar E, Negreanu-Pirjol T, Pascale C, Sirbu R, Prasacu I, Negreanu-Pirjol B Antioxidants (Basel). 2023; 12(11).

PMID: 38001761 PMC: 10669212. DOI: 10.3390/antiox12111907.